This mechanism leads to a reduction in adipocyte volume , which could alleviate the lipid overload observed in cellulite
By Suzanne Fenske, MD, FACOG, ABOIM, MSCP GLP-1 receptor agonist medications, including semaglutide (Ozempic), tirzepatide (Monjaro), and liraglutide (Victoza), are FDA-approved for weight loss and diabetes
Because tirzepatide (brand name Mounjaro) was only approved by the FDA in mid-2022 for type 2 diabetes, the ability to rigorously analyze its use (on- and off-label) for a broad population of patients with overweight or obesity, not just a subset captured in insurance databases, has the power to greatly improve our understanding of how these agents are being used in every day practice and the effect that theyre having.
In HH, total body iron stores can be calculated from the volume of blood removed during weekly venesections
J Physiol Pharmacol 61(2):241250 Ilic S, Drmic D, Franjic S et al (2011a) Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions